Cordyceps
6 benefits mapped to clinical evidence across supplements.
Dose per serving from products
400 products in our catalogue print how much Cordyceps a serving holds.
Most common: 250 mg to 500 mg, 44% of 400 products.
| Dose per serving | Products |
|---|---|
| 10 mg or less | 6 |
| 10 mg to 25 mg | 20 |
| 25 mg to 50 mg | 22 |
| 50 mg to 100 mg | 49 |
| 100 mg to 250 mg | 67 |
| 250 mg to 500 mg | 177 |
| 500 mg to 1 g | 43 |
| over 1 g | 16 |
Dose per serving from research
14 study groups in 11 studies say how much Cordyceps participants took a day.
These are the doses the studies gave. They are not a recommendation.
Most common: 1 g to 2.5 g, 43% of 14 study groups.
| Daily dose | Study groups |
|---|---|
| 500 mg to 1 g | 2 |
| 1 g to 2.5 g | 6 |
| 2.5 g to 5 g | 3 |
| 5 g to 10 g | 3 |
Benefit Evidence
Innate immunity ↑ (NK +34%)
Post-transplant infections ↓ (−10.8%)
Research sources
Immune support (5)
- [Clinical study on application of bailing capsule after renal transplantation]
PubMed ID: 15495826
Post-kidney-transplant randomized trial reported fewer infections when Bailing (Cordyceps) was added—clinically relevant immune effect.
- Cordyceps militaris Enhances Cell-Mediated Immunity in Healthy Korean Men
PubMed ID: 26284906
Double-blind RCT in healthy men showed increased NK activity, lymphocyte proliferation and IL-2—strong immune activation signals.
- A randomized controlled clinical trial examining the effects of Cordyceps militaris beverage on the immune response in healthy adults
PubMed ID: 38580687
Cordyceps militaris beverage increased NK activity and modulated cytokines in healthy adults (RCT).
- Clinical application of Cordyceps sinensis on immunosuppressive therapy in renal transplantation
PubMed ID: 19545680
Large adjunct transplant study showed fewer graft complications and less infection/nephrotoxicity with Cordyceps—consistent with immune/clinical protection.
- Immunomodulatory effects of a mycelium extract of Cordyceps (Paecilomyces hepiali; CBG-CS-2): a randomized and double-blind clinical trial
PubMed ID: 30925876
8-week double-blind trial in healthy adults reported significant increase in NK-cell activity with Cordyceps mycelium extract.
Vitality (4)
- Effect of Dongchongxiacao (Cordyceps) therapy on contrast-induced nephropathy in patients with type 2 diabetes and renal insufficiency undergoing coronary angiography
PubMed ID: 26427112
Reduced contrast-induced kidney injury and eGFR decline in high-risk patients—protects organ function and overall health.
- [Clinical study on application of bailing capsule after renal transplantation]
PubMed ID: 15495826
Post-transplant trial reported fewer infections, improved liver tests and higher HDL—broad clinical benefits relevant to vitality.
- [Treatment of chronic allograft nephropathy with combination of enalapril and bailing capsule]
PubMed ID: 19065894
In chronic allograft nephropathy, adding Bailing improved renal function and proteinuria—clinically relevant for health/vitality.
- Clinical application of Cordyceps sinensis on immunosuppressive therapy in renal transplantation
PubMed ID: 19545680
Large adjunct trial after transplant showed fewer graft complications, less drug toxicity and lower immunosuppressant need—meaningful clinical vitality/health signal.
Sexual wellness (1)
- [Cordyceps sinensis combined with Jujing Pills for male infertility]
PubMed ID: 34914281
Randomized trial in infertile men found substantial improvements in progressive motility, morphology and reduced DNA fragmentation when Cordyceps was added—direct improvement in semen quality relevant to sexual/ reproductive vitality.
Stress resilience (1)
- [Effect of combined therapy with hypha Cordyceps and ginkgo leaf tablet on micro-inflammation in patients undergoing maintenance hemodialysis]
PubMed ID: 18655556
Reductions in hs-CRP, IL-6 and TNF-α in hemodialysis patients indicate lowered systemic inflammation, a pathway for improved physiological stress resilience.
Metabolism (1)
- [Clinical research of xinganbao capsule on the treatment of chronic hepatitis B liver fibrosis]
PubMed ID: 22686076
Randomized trial in chronic hepatitis B showed lower ALT/AST and histologic improvement—meaningful metabolic/hepatic benefits.
Respiratory comfort (1)
- [Effect of dongchong xiacao capsule on airway inflammation of asthmatic patients]
PubMed ID: 17972591
Adjunct Cordyceps capsules in asthma lowered IgE, IL-4 and MMP-9—markers of airway inflammation, suggesting potential benefit for breathing capacity in moderate asthmatics.
Similar by evidence
Supplements the same benefits carry qualifying findings for — a fact about the evidence graph, not a recommendation to swap.
Products with Cordyceps
Search all1062 products whose verified label declares Cordyceps — not every bottle that mentions it in a title.
Being studied right now
Recruiting clinical trials registered on ClinicalTrials.gov. A trial in progress has no result yet — this is what the field is asking, not what it found.